Cargando…

Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phase II trial (ClinicalTrials.gov NCT03241914)

OBJECTIVE: To evaluate the effect of levonorgestrel-releasing intrauterine system (LNG-IUS) plus oral megestrol acetate (MA) as fertility-preserving treatment in patients with early-stage endometrial cancer (EEC). METHODS: In this single-center, phase II study with open-label, randomized and control...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhiying, Yang, Bingyi, Guan, Jun, Shan, Weiwei, Liao, Jiongbo, Shao, Wenyu, Chen, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807359/
https://www.ncbi.nlm.nih.gov/pubmed/36562136
http://dx.doi.org/10.3802/jgo.2023.34.e32